Melanie Schwiesow, MD
Vascular Surgery · Saint Louis, MONPI 1689091878
Payments from drug & device makers
What this record shows
29 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 30.6% of the total.
Across 85 payments — averaging $88.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$2K
- Centinel Spine, LLC$2K
- Silk Road Medical, Inc.$1K
- Endologix LLC$567
- Penumbra, Inc.$442
- Bolton Medical Inc$338
- plus $1K from 23 others
Across 14 payments — averaging $1438.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- W. L. Gore & Associates, Inc.$20K
What the payments were for
- Travel & lodging$3,09041%
- Food & beverage$4,44359%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 18 | $2,305 |
| Centinel Spine, LLC | 3 | $1,535 |
| Silk Road Medical, Inc. | 10 | $1,088 |
| Endologix LLC | 6 | $567 |
| Penumbra, Inc. | 4 | $442 |
| Bolton Medical Inc | 3 | $338 |
| Medtronic | 10 | $265 |
| Bard Peripheral Vascular, Inc. | 2 | $240 |
| Abiomed | 2 | $133 |
| Angiodynamics, Inc. | 2 | $96 |
| Johnson & Johnson(2 entities) | 3 | $57 |
| Shockwave Medical, Inc | 2 | $52 |
| Getinge USA Sales, LLC | 1 | $49 |
| Terumo Medical Corporation | 2 | $39 |
| Integra Lifesciences Corporation | 2 | $39 |
| Cashflow Solutions, LLC | 2 | $35 |
| Edwards Lifesciences | 1 | $26 |
| Solventum Corporation | 1 | $26 |
| Atricure, Inc. | 1 | $26 |
| Cardiovascular Systems Inc. | 1 | $24 |
| Surgical Specialties Corporation (US), Inc. (dba Corza Medical) | 1 | $20 |
| Neuros Medical, Inc. | 1 | $20 |
| Stryker | 1 | $19 |
| Tactile Systems Technology Inc | 1 | $18 |
| Smith+Nephew | 1 | $18 |
| Abbott | 1 | $18 |
| Lemaitre Vascular, Inc. | 1 | $14 |
| Amgen | 1 | $14 |
| Lifenet Health | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PRODISC L$1,535
- ENROUTE Transcarotid Neuroprotection System$1,175
- ENROUTE Transcarotid Stent System$740
- ENHANCE Transcarotid Peripheral Access Kit$740
- ENROUTE 0.014 Guidewire$740
- GORE TAG Thoracic Branch Endoprosthesis$529
- GORE TAG Thoracic Endoprosthesis$517
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$318
- GORE VIABAHN VBX Balloon Expandable Endo$303
- Alto Abdominal Stent Graft System$254
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$218
- ENROUTE Transcarotid Stent$218
- RUBY Coil$171
- GORE ACUSEAL Vascular Graft$157
- VIABAHN Endoprosthesis with Heparin Bioactive Surface$155
- TREO ABDOMINAL STENT-GRAFT SYSTEM$145
- LUTONIX$142
- Torus Stent Graft System$140
- ENDOCROSS Device$140
- Penumbra System$132
How this compares
$7,533 in reported general payments places this provider in the 55th percentile of 92 vascular surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 17 | $13,615 |
| EliquisApixaban | 14 | $8,046 |
| Cilostazol | 64 | $1,251 |
| Atorvastatin Calcium | 38 | $461 |
| Pentoxifylline | 11 | $405 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 54 | $377 |
| ClopidogrelClopidogrel Bisulfate | 48 | $373 |
| Gabapentin | 12 | $108 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $57 | $13,61517 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 92 vascular surgery providers in Missouri.
Other vascular surgery in Saint Louis
- Jeffrey JimSaint Louis$1.2M
- Brian PetersonSaint Louis$216K
- Luis SanchezSaint Louis$178K
- Catherine WittgenSaint Louis$139K
- John OhmanSaint Louis$113K
- Patrick GeraghtySaint Louis$65K
- Nathan DrozSaint Louis$38K
- Mohamed ZayedSaint Louis$30K
- Vipul KhetarpaulSaint Louis$23K
- Zachary WankenSaint Louis$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.